{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-009499","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2024-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.236694+00:00","generated_at":"2026-06-05T14:26:53.594288+00:00","sec_items":["7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"STRATA Skin Sciences amends credit agreement, removes 2023 revenue covenants","bullets":["Amendment No. 4 removes minimum revenue requirements for 2023 and introduces future financial covenants.","Effective February 20, 2024; aligns credit terms with current and projected business operations.","Enhances liquidity and financial flexibility to support operational and capital needs.","CEO Dolev Rafaeli states amendment strengthens partnership with MidCap and enables strategic initiatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-009499","json":"https://secwatch.observer/filing/0001140361-24-009499.json","markdown":"https://secwatch.observer/filing/0001140361-24-009499.md","text":"https://secwatch.observer/filing/0001140361-24-009499.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000114036124009499/0001140361-24-009499-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000114036124009499/ef20022417_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T14:26:53.594288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}